Search results - 179 results

Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.

H9-specific cell-mediated immunity, and protection conferred by the rHVT- H9-F vaccine in specific pathogen-free (SPF) chickens. Vaccination elicited systemic NDV F- and AIV H9-specific antibody response but ...

Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial.

Kantele, Anu Source: Clin Microbiol Infect, Volume 29, Issue 12 (2023) Keywords: ADOLESCENT Adult Antibodies, Bacterial Double-Blind Method Hepatitis A Hepatitis A Antibodies Hepatitis A Vaccines Humans ...

Development of a multiplex-based immunoassay for the characterization of diphtheria, tetanus and acellular pertussis antigens in human combined DTaP vaccines.

Thierry; Hoebreck, Charline; Stickings, Paul; Alexandre Dobly Source: J Immunol Methods, Volume 517 (2023) Keywords: Animals Antibodies, Bacterial Antigens Diphtheria Diphtheria-Tetanus-acellular Pertussis ...

Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.

J Transplant, Volume 23, Issue 5 (2023) Keywords: Antibodies, Neutralizing Antibodies, Viral BNT162 Vaccine Breakthrough Infections Cohort Studies COVID-19 Humans Immunoglobulin G Interferon-gamma Kidney ...

Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.

Antibodies, Viral BNT162 Vaccine Breakthrough Infections COVID-19 COVID-19 Vaccines Humans Immunity nursing homes Population Groups RNA, Messenger SARS-CoV-2 Abstract: BACKGROUND: Nursing home residents, ...

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.

have decreased antibody responses upon vaccination targeting other viral antigens. OBJECTIVES: As real-world data on vaccine responsiveness, we assessed the prevalence of SARS-CoV-2 antibodies among ...

Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.

Longevity of antibodies was supported by booster vaccination and virus circulation. TRIAL REGISTRATION NUMBER: NCT04779424. Service:  Réponse immunitaire Immuunrespons Immune response Manuscript versions:  ...

Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.

Stéphanie Humblet-Baron Source: Front Immunol, Volume 13 (2022) Keywords: 2019-nCoV Vaccine mRNA-1273 Antibodies, Viral BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans Immunocompromised Host mRNA Vaccines ...

Ultrastable Silver Nanoparticles for Rapid Serology Detection of Anti-SARS-CoV-2 Immunoglobulins G.

Olivier; Gilles Bruylants; Ivan Jabin Source: Anal Chem, Volume 94, Issue 20 (2022) Keywords: Antibodies, Viral Calixarenes COVID-19 Gold Humans Immunoassay Immunoglobulin G Metal Nanoparticles SARS-CoV-2 ...

QR code

QR code for this page URL